Ghatan Christine E, Ryu Robert K
Department of Radiology, University of Colorado Denver, Aurora, Colorado.
Semin Intervent Radiol. 2016 Jun;33(2):75-8. doi: 10.1055/s-0036-1582123.
Inferior vena cava (IVC) filtration for thromboembolic protection is not without risks, and there are important differences among commercially available IVC filters. While retrievable filters are approved for permanent implantation, they may be associated with higher device-related complications in the long term when compared with permanent filters. Prospective patient selection in determining which patients might be better served by permanent or retrievable filter devices is central to resource optimization, in addition to improved clinical follow-up and a concerted effort to retrieve filters when no longer needed. This article highlights the differences between permanent and retrievable devices, describes the interplay between these differences and the clinical indications for IVC filtration, advises against a "one-filter-for-all" approach to mechanical thromboembolic prophylaxis, and discusses strategies for optimizing personalized device selection.
下腔静脉(IVC)滤器用于预防血栓栓塞并非没有风险,而且市面上的IVC滤器存在重要差异。虽然可回收滤器已获批可永久植入,但与永久性滤器相比,长期来看它们可能与更高的器械相关并发症有关。除了改善临床随访以及在不再需要时协同努力取出滤器外,前瞻性地选择患者以确定哪些患者可能更适合使用永久性或可回收滤器装置对于资源优化至关重要。本文强调了永久性和可回收装置之间的差异,描述了这些差异与IVC滤器临床适应证之间的相互作用,不建议采用“一刀切”的机械性血栓栓塞预防方法,并讨论了优化个性化装置选择的策略。